+1 855 SEE OMEGA (855-733-6634)
Our Mission. Our Services. Our Values.
OMEGA Research Group is a premier research organization with several locations located throughout the Central Florida and coastal Florida regions. Built on the foundations of Compassion, Excellence, and Integrity, OMEGA Research Group are quickly becoming a known leader in clinical trial operations throughout America.
See if you Qualify
Current Studies
Why participate in a study?
To participate in a study:
-
Call 1-855-SEE-OMEGA (1-855-733-6634) to speak with a Recruitment Specialist who will ask you a series of questions to determine your suitability for the study.
-
You may also complete the on-line form below and a Recruitment Specialist will contact you.
To take control of your healthcare
Participating in a study puts you in the driver's seat. You will learn more about your disease and available treatments with your study team to guide you along the way.
​
To gain early access to new and groundbreaking treatments
Every single drug on the market today went through the trial process, including those that are now considered the gold-standard for treatment of many diseases.
To receive expert medical care, free of cost
A dedicated team of doctors, nurses and other health professionals put your safety and well-being above all else. You do not need insurance to participate. Everything, including the doctor's time, all diagnostic tests and the study treatment itself, is of no cost to you.
Gastrointestinal
Ulcerative Colitis
Ulcerative Colitis is a chronic condition limited to the large intestine (colon and rectum). It is an inflammatory bowel disease that causes inflammation in the digestive tract with symptoms that may include rectal bleeding, bloody diarrhea, abdominal cramps, and pain.
Inflammatory & Immune System
Lupus Nephritis
Doctors are looking for patients to participate in a study evaluating the safety and effectiveness of an investigational medication for patients with lupus nephritis.You may pre-qualify for this study if you are age 18 to 7 5, are diagnosed with systemic lupus
erythematosus (SLE), and have active lupus nephritis. Additional requirements apply.
​